Abstract
The synthesis and the pharmacological evaluation of 1,8-naphthyridine derivatives and related compounds as inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), as well as voltage-dependant Ca2+ channels (VDCC) modulators of are summarized. These compounds are closely related to the anticholinesterasic tacrine and the well-known Ca2+-antagonists 1,4-dihydropyridines. They were obtained from polyfunctionalized 2-amino-3-cyanoheterocycles via Friedlander-type reaction with selected cycloalkanones. Most of the compounds showed moderate inhibitory activity of cholinesterases, with selectivity to the AChE inhibition, and blocked Ca2+ channels, preferentially the Lsubtype, when a 4-aryl-1,4-DHP-like moiety were present in its chemical structure. Taking into account that the regulation of Ca2+ entry to cells has been described to play a key role in cell death/survival processes, some of them were studied as cytoprotective agentes against different toxic stimuli. Specifically, the 1,8-naphthyridine derivative 30 was described to exert a tiny positive effect on Ca2+ entry to cells, as single cell, isolated organ, and 45Ca2+ uptake experiments showed. This slight “Ca2+-promoter” behavior was related to its cytoprotective effect against several toxic stimuli, as Ca2+- chelating and antiapoptotic protein Bcl-2 was overexpressed in bovine chromaffin cells preincubated with 30. In fact, the relationship between small elevations of [Ca2+]c and neuroprotection has been deeply studied by our group and others, concluding that a huge blockade of Ca2+ entry does not have to generate neuroprotection, but the precise regulation, up or down, of such [Ca2+] concentrations.
Keywords: Acetylcholinesterase, alzheimer's disease, drug discovery, friedlander reaction, 1, 8-naphthyridines, voltagedependant calcium channels, pharmacological evaluation, acetylcholinesterase (AChE), voltage-dependant Ca2+, antiapoptotic protein, inhibiting acetylcholinesterase(AChE), polyfunctionalized 4H-pyrans, amyloid fibrils aggregation, cycloalkanone, aluminum trichloride
Current Topics in Medicinal Chemistry
Title: 1,8-Naphthyridine derivatives as Cholinesterases Inhibitors and Cell Ca2+ Regulators, a Multitarget Strategy for Alzheimer's Disease
Volume: 11 Issue: 22
Author(s): Javier Egea and Cristobal de los Rios
Affiliation:
Keywords: Acetylcholinesterase, alzheimer's disease, drug discovery, friedlander reaction, 1, 8-naphthyridines, voltagedependant calcium channels, pharmacological evaluation, acetylcholinesterase (AChE), voltage-dependant Ca2+, antiapoptotic protein, inhibiting acetylcholinesterase(AChE), polyfunctionalized 4H-pyrans, amyloid fibrils aggregation, cycloalkanone, aluminum trichloride
Abstract: The synthesis and the pharmacological evaluation of 1,8-naphthyridine derivatives and related compounds as inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), as well as voltage-dependant Ca2+ channels (VDCC) modulators of are summarized. These compounds are closely related to the anticholinesterasic tacrine and the well-known Ca2+-antagonists 1,4-dihydropyridines. They were obtained from polyfunctionalized 2-amino-3-cyanoheterocycles via Friedlander-type reaction with selected cycloalkanones. Most of the compounds showed moderate inhibitory activity of cholinesterases, with selectivity to the AChE inhibition, and blocked Ca2+ channels, preferentially the Lsubtype, when a 4-aryl-1,4-DHP-like moiety were present in its chemical structure. Taking into account that the regulation of Ca2+ entry to cells has been described to play a key role in cell death/survival processes, some of them were studied as cytoprotective agentes against different toxic stimuli. Specifically, the 1,8-naphthyridine derivative 30 was described to exert a tiny positive effect on Ca2+ entry to cells, as single cell, isolated organ, and 45Ca2+ uptake experiments showed. This slight “Ca2+-promoter” behavior was related to its cytoprotective effect against several toxic stimuli, as Ca2+- chelating and antiapoptotic protein Bcl-2 was overexpressed in bovine chromaffin cells preincubated with 30. In fact, the relationship between small elevations of [Ca2+]c and neuroprotection has been deeply studied by our group and others, concluding that a huge blockade of Ca2+ entry does not have to generate neuroprotection, but the precise regulation, up or down, of such [Ca2+] concentrations.
Export Options
About this article
Cite this article as:
Egea Javier and de los Rios Cristobal, 1,8-Naphthyridine derivatives as Cholinesterases Inhibitors and Cell Ca2+ Regulators, a Multitarget Strategy for Alzheimer's Disease, Current Topics in Medicinal Chemistry 2011; 11 (22) . https://dx.doi.org/10.2174/156802611798184418
DOI https://dx.doi.org/10.2174/156802611798184418 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator
Medicinal Chemistry Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Pharmacotherapy of Down’s Syndrome: When and Which?
CNS & Neurological Disorders - Drug Targets Drugs and Medicines in Pregnancy: The Placental Disposition of Opioids
Current Pharmaceutical Biotechnology Advances in Studies on Neurodegenerative Diseases and their Treatments
Current Topics in Medicinal Chemistry Melanocortins and their Receptors and Antagonists
Current Drug Targets Pharmacogenetic Insights into Depression and Antidepressant Response: Does Sex Matter?
Current Pharmaceutical Design Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders
Current HIV Research Neuroscience of Exercise: Association Among Neurobiological Mechanisms and Mental Health
CNS & Neurological Disorders - Drug Targets Therapeutic Strategies for Treatment-resistant Depression: State of the Art and Future Perspectives
Current Pharmaceutical Design From the Prodrome to Chronic Schizophrenia: The Neurobiology Underlying Psychotic Symptoms and Cognitive Impairments
Current Pharmaceutical Design Steroid Receptor Ligands for Breast Cancer Targeting: An Insight into Their Potential Role As Pet Imaging Agents
Current Medicinal Chemistry Vascular Endothelial Dysfunction and Nutritional Compounds in Early Type 1 Diabetes
Current Diabetes Reviews Meet Our Associate Editorial Board Member
Protein & Peptide Letters Development and Tailoring of Hybrid Lipid Nanocarriers
Current Pharmaceutical Design Methadone and the Heart: What the Clinician Needs to Know
Current Drug Abuse Reviews Editorial (Thematic Issue: Overview of Immunotherapy in Alzheimer’s Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD)
Current Alzheimer Research Antipsychotics Management in Addictive Disorders
Current Psychopharmacology Meet Our Editorial Board Members:
Central Nervous System Agents in Medicinal Chemistry The Mechanism of Action of Antidepressants: A Unitary Hypothesis Based on Transport-P
Current Drug Targets - CNS & Neurological Disorders